Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

Clinical trial NCT05383560 · COMPLETED

Trial details

NCT number: NCT05383560
Sponsor: Sheba Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pandemic Immunogenicity SARS CoV 2 Infection COVID-19

Start date: 2022-09-05
Primary completion: 2024-01-31
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.